PDB17 A COMPARISON OF COSTS AMONG PATIENTS WITH TYPE 2 DIABETESWHO INITIATED THERAPY WITH EXENATIDE OR INSULIN GLARGINE
Abstract
Authors
DA Misurski R Fabunmi KS Boye MJ Lage
DA Misurski R Fabunmi KS Boye MJ Lage
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now